We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Prenatal MRI Detects Rare Genetic Disease in Newborn

By HospiMedica International staff writers
Posted on 13 Apr 2010
In a case believed to be a United States first, a radiology team has utilized prenatal magnetic resonance imaging (MRI) to detect an often-misdiagnosed genetic disease, congenital chloride diarrhea (CCD; also congenital chloridorrhea). More...


The disorder can cause severe dehydration and serious metabolic disturbances in newborns if not treated quickly. "This is a disease where early diagnosis is the key to a good outcome,” said Richard Barth, M.D., chief radiologist at the Lucile Packard Children's Hospital (Palo Alto, CA, USA), and the physician who recognized the unusual case. Congenital chloride diarrhea is so rare, with only approximately 250 total cases reported worldwide, that infants with the disease are frequently erroneously treated for other diarrhea-causing ailments. "If the patient's fortunate, you could stumble onto this diagnosis,” said Dr. Barth, a professor of pediatric radiology at the Stanford University School of Medicine (Stanford, CA, USA). The case was the first instance of CCD Dr. Barth had ever seen.

The diagnosis is one of only four known cases of CCD diagnosis ever made via prenatal MRI scanning. A scientific report on the four cases, including Dr. Barth's case and three from France, was published online December 9, 2010, in the journal Ultrasound in Obstetrics & Gynecology. The report is a collaboration between Dr. Barth and a team of French scientists in Marseilles.

Dr. Barth made his diagnosis in February 2009 when an expectant mother was referred to him for follow-up of an abnormal prenatal ultrasound. The ultrasound showed classic signs of bowel obstruction, a typical fetal problem. To get more information about the fetus, Dr. Barth ordered an MRI scan, which gave him a surprise that could not have been detected by ultrasound: Instead of showing the fetal colon filled with solid waste, as in a bowel obstruction, it was filled with fluid. This important clue, found due to the Packard team's expertise in fetal MRI, pointed Dr. Barth toward the obscure diagnosis of CCD.

When the baby was born at Packard a few weeks later, Dr. Barth collaborated with obstetrics and neonatology teams in the hospital's Johnson Center for Pregnancy and Newborn Services to ensure the infant's fluid and electrolyte levels would be monitored beginning at birth. This was needed because the gene mutation that causes CCD damages a salt-transporting protein in the intestine. The abnormality stops the body from absorbing essential electrolytes, causing patients to have large amounts of watery, high-salt diarrhea.

"These babies can go into shock and die because of the tremendous electrolyte imbalance at birth,” said Maurice Druzin, M.D., professor and service chief of obstetrics and gynecology at Packard Children's. Without the prenatal diagnosis, it could easily have taken physicians a few days to figure out what was going on, Dr. Druzin added. "The baby could have been in serious trouble by that time,” he said. Untreated patients who survive early life may suffer permanent kidney damage, feeding problems, severe malnutrition, and delays in growth and motor development.

"In this case, the neonatology team was not just monitoring the baby's electrolytes, but also taking special precautions in terms of feeding,” stated neonatologist Susan Hintz, M.D., associate professor and medical director of the Center for Comprehensive Fetal Health & Maternal and Family Care at Packard Children's. "We took these steps due to the strong possibility that this was CCD.”

For infants whose CCD is detected early, treatment is simple: intravenous fluid and salt replacement can compensate for their ongoing diarrhea. As they get older, patients may take extra liquids and salts by mouth, or they can opt for newer treatments. For instance, the little girl Dr. Barth diagnosed is now taking an oral medication that modifies her body's salt uptake and reduces diarrhea. Although these treatments do not cure the disease, prompt diagnosis and treatment allow patients to lead normal, healthy lives.

"Dr. Barth's experience with difficult cases and the depth of his familiarity with the fetal imaging scientific literature really helped our entire team provide the best possible care for this mother and baby,” Dr. Hintz said.

Related Links:
Lucile Packard Children's Hospital


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Pressure Guidewire
SavvyWire
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.